Will take at least 2 years for Covid vaccine to reach everyone  ThePrintView Full Coverage on Google News

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine | InvestorPlace

The speed in developing vaccines for widespread testing this summer is impressive, but running trials involving tens of thousands of people will be an immense undertaking.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: Fast coronavirus vaccine could bring problems - Los Angeles Times

Bloomberg - Are you a robot?

Will vaccine for COVID-19 play into the developing narrative of seeing a shift of technological and scientific innovation from the Global North to the Global South? Or will the race simply re-instate the Cold War notion of Western world dominance?Will COVID vaccine shift narrative in technological & scientific innovation from Global North to Global South? 

Will India Overtake China As Global Power If It Wins the Vaccine Race? | OPINION

He attacks Joe Biden to deflect blame for his terrible handling of Covid-19 and record of appeasing Beijing.He attacks Joe Biden to deflect blame for his terrible handling of Covid-19 and record of appeasing Beijing.

If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.

Analysis: Get ready for the vaccine — they’re never simple

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Part of what makes me proud to be an Ontarian is the people. Ontario has been the home to many scientific discoveries, there’s no reason we can’t find a vaccine for #COVID19 right here. We’re supporting promising proposals that are looking for long-term solutions. https://t.co/gHLtDN256i”

Doug Ford on Twitter: "Part of what makes me proud to be an Ontarian is the people. Ontario has been the home to many scientific discoveries, there’s no reason we can’t find a vaccine for #COVID19 right here. We’re supporting promising proposals that are looking for long-term solutions.… https://t.co/6zs6TaKwbQ"

“FDA shuffles longtime division hed, Janet Woodcock, to focus exclusively on a Covid-19 vaccine project https://t.co/i7ikpkNGZA via @statnews”

Adam Feuerstein on Twitter: "FDA shuffles longtime division hed, Janet Woodcock, to focus exclusively on a Covid-19 vaccine project https://t.co/i7ikpkNGZA via @statnews"

Please click the link below to subscribe to a FREE PDF version of each print edition of the Niagara Reporter http://eepurl.com/dnsYM9     By:Please click the link below to subscribe to a FREE PDF version of each print edition of the Niagara Reporter http://eepurl.com/dnsYM9     By: Staff Reporter During a CNN Town Hall on Thursday, May 21st, 2020, NIAID Director Anthony Fauci said he’s “cautiously optimistic” about a Moderna COVID-19, Coronavirus, vaccineRead More

Fauci "Cautiously Optimistic" on Moderna Vaccine - The Niagara Reporter

FoxNews.com

404 | Fox News

Reuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end. By Adam ButtonReuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end.

US will test vaccines on more than 100,000 people starting in July - report

In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka. <p>In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka.</p>

Vaccine expert Peter Hotez reveals 3 things to help Houston reopen, avoid second surge of COVID-19 - HoustonChronicle.com

About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.

Coronavirus, vaccine, Michigan flooding, Ford, unemployment: Thursday's news

Dr. Anthony Fauci says it's "conceivable" a coronavirus vaccine could be ready within months but cautions "when you're dealing with vaccines, there could be so many things that get in the way."Dr. Anthony Fauci says it's "conceivable" a coronavirus vaccine could be ready within months but cautions "when you're dealing with vaccines, there could be so many things that get in the way."

Fauci Optimistic About Moderna Vaccine Trial : Shots - Health News : NPR

Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.

Why Moderna Stock Dropped Thursday | The Motley Fool

The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: While the U.S. rushes to develop a COVID-19 vaccine, here's what science tells us

1/VACCINE RACE1/VACCINE RACE

Take Five: Coronavirus vaccine race is on - Reuters

Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.

A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says - Barron's

The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial

Moderna provides cursory glance at first COVID-19 vaccine data

Less than two-thirds of Americans are "very" or "somewhat" interested in getting a COVID-19 vaccine if one becomes available, according to a Reuters/Ipsos...Less than two-thirds of Americans are "very" or "somewhat" interested in getting a COVID-19 vaccine if one becomes available, according to a Reuters/Ipsos...

Poll finds many Americans wary of taking coronavirus vaccine: report - MarketWatch

Blood samples from a group of 108 vaccinated adults showed both neutralizing antibodies and T-cell responses against the novel coronavirus in most of those tested. "However ... the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans fromBlood samples from a group of 108 vaccinated adults showed both neutralizing antibodies and T-cell responses against the novel coronavirus in most of those tested. "However ... the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans from

CanSino coronavirus vaccine appears safe in first human trial

A quarter of Americans say they have little or no interest in getting vaccinated for the coronavirus, with some voicing concerns about the speedy development process.A quarter of Americans say they have little or no interest in getting vaccinated for the coronavirus, with some voicing concerns about the speedy development process.

1 in 4 have little or no interest in getting coronavirus vaccine, noting speed of development: poll | TheHill

A quarter of Americans say they have little or no interest in getting vaccinated for the coronavirus, with some voicing concerns about the speedy development process.A quarter of Americans say they have little or no interest in getting vaccinated for the coronavirus, with some voicing concerns about the speedy development process.

1 in 4 have little or no interest in getting coronavirus vaccine, noting speed of development: poll | TheHill

Covid-19 vaccine trials: Is there a vaccine for coronavirus? A massive effort is planned for the U.S. to meet year-end goals.Between 100,000 to 150,000 volunteers expected to be enrolled in half a dozen vaccine trials this summer, scientists say.

Hello, Welcome to Dispensed, Business Insider's weekly healthcare newsletter. We've made it to Memorial Day weekend! Hope everyone's found a restful way toWelcome to Dispensed. Inside, how the pandemic has transformed the drug industry and how hospitals handle future surges of patients.

Dispensed: Vaccine updates — Coronavirus medical bills — COVID-19 skin complications | Business Insider India

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

In this episode, we break down Moderna's early-stage results from a coronavirus vaccine and the reaction from unsatisfied experts around the globe.In this episode, we break down Moderna's early-stage results from a coronavirus vaccine and the reaction from unsatisfied experts around the globe.

Listen: Moderna's scant coronavirus data & the world's reliance on biotech

Vaccine developers have four major strategies in their efforts to make a coronavirus vaccine: gene-based, adenovirus vectors, inactivated, and protein subunit. All have pros and cons, both around how they provide protection from a virus and how they’re manufactured.There are other options if they don’t work.

Unproven strategies lead the race for a COVID-19 vaccine - The Verge

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

A new poll from Reuters and Ipsos has found that a quarter of Americans weren't interested in taking a Covid-19 vaccine, which doesn't even exist.Covid-19 has wreaked havoc on the world, causing 5 million recorded infections and 333,000 deaths so far, with a third of the world under lockdown. In orde

A Quarter Of Americans Are Hesitant About Taking A Covid-19 Vaccine That Doesn't Yet Exist | IFLScience

Dr. Anthony Fauci said he's optimistic about one of the CCP virus vaccine candidates quickly moving through clinical ...Dr. Anthony Fauci said he's optimistic about one of the CCP virus vaccine candidates quickly moving through clinical ...

Fauci ‘Cautiously Optimistic’ About Leading CCP Virus Vaccine Candidate

by Sanjay Mishra, Vanderbilt University Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on Wall St

What the phase 1 trials of the first COVID-19 vaccine really mean – Alternet.org

It feels like our only hope against coronavirus, so...when will a COVID-19 vaccine be ready? Experts explain the development timeline from start to finish.Be prepared for a long wait.

When will a COVID-19 vaccine be ready? Be ready to wait | Well+Good

On Tuesday 12 May, Moderna Therapeutics received Fast Track designation from the Food and Drug Administration (FDA) for its Covid-19 candidate vaccine.On Tuesday 12 May, Moderna Therapeutics received Fast Track designation from the Food and Drug Administration (FDA) for its Covid-19 candidate vaccine.

Moderna Covid-19 vaccine looks to gain first approval

The vaccine appeared "generally safe and well-tolerated" on volunteers.The vaccine appeared "generally safe and well-tolerated" on volunteers.

Fauci on Moderna vaccine: "I'm cautiously optimistic" - Axios

The Oxford trial will monitor the effects on thousands of people's immune systems.The Oxford trial will monitor the effects on thousands of people's immune systems.

Coronavirus: Children and older adults to take part in vaccine trial - BBC News

Dr. Fauci expressed confidence in a new vaccine being developed by a Massachusetts firm

Coronavirus vaccine for United States possible by December, Dr. Anthony Fauci says; ‘I think it is conceivable’ - masslive.com

Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.

Coronavirus vaccine current update / COVID-19 vaccines drugs latest news: Oxford vaccine failure to Moderna’s favourable results, here is the latest status of COVID-19 vaccines and drugs

Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.

Coronavirus vaccine current update / COVID-19 vaccines drugs latest news: Oxford vaccine failure to Moderna’s favourable results, here is the latest status of COVID-19 vaccines and drugs

NoCookies | The Australian

NEW YORK (REUTERS) - A quarter of Americans have little or no interest in taking a coronavirus vaccine, a Reuters/Ipsos poll published on Thursday (May 21) found, with some voicing concern that the record pace at which vaccine candidates are being developed could compromise safety.. Read more at straitstimes.com.United States News -NEW YORK (REUTERS) - A quarter of Americans have little or no interest in taking a coronavirus vaccine, a Reuters/Ipsos poll published on Thursday (May 21) found, with some

One in four Americans hesitant about coronavirus vaccine, one-third less willing to take it if Trump says it's safe: Poll, United States News & Top Stories - The Straits Times

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker